Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.05.055
Abstract: Objectives One of the most significant features of poor prognosis in Coronavirus disease 2019 (COVID-19) is pulmonary fibrosis. Nintedanib is a new antifibrotic agent that interferes with processes of pulmonary fibrosis. This study aimed to… read more here.
Keywords: fibrosis; efficacy safety; pulmonary fibrosis; interventional study ... See more keywords